1. Home
  2. EVO vs ASST Comparison

EVO vs ASST Comparison

Compare EVO & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.98

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Asset Entities Inc. Class B

ASST

Asset Entities Inc. Class B

HOLD

Current Price

$0.79

Market Cap

913.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
ASST
Founded
1993
2020
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
913.3M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
EVO
ASST
Price
$2.98
$0.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$1.50
AVG Volume (30 Days)
107.8K
90.7M
Earning Date
11-05-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$887,396,457.00
$5,512,106.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
125.01
52 Week Low
$2.84
$0.78
52 Week High
$5.10
$7.89

Technical Indicators

Market Signals
Indicator
EVO
ASST
Relative Strength Index (RSI) 40.01 32.79
Support Level $2.86 $0.88
Resistance Level $3.09 $1.04
Average True Range (ATR) 0.10 0.08
MACD 0.01 0.01
Stochastic Oscillator 24.49 1.88

Price Performance

Historical Comparison
EVO
ASST

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About ASST Asset Entities Inc. Class B

Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.

Share on Social Networks: